Step Therapy News Today

>> sean: i cant just abandon it. >> laura: i love dr. phil. i loved that interview. i was mad i didnt get it. loved watching him. you guys were cute together. >> sean: were not competitors. we are colleagues. as long as we kick everybody elses ass its fine. >> laura: i am laura ingraham and this is "the ingraham angle." nowhere to hide is the focus of tonights "angle." we were excited for an hour long interview with president biden but jake tapper only got 15 minutes. thats hardly enou...

Kim Albin has lost count of the number of times she’s had to battle health insurance companies over medications. Albin, who has been living with multiple sclerosis for nearly 30 years, said health insurers have told her time and again that they won’t cover medications her doctors have prescribed until she first tries alternate, often cheaper, ones. “It’s like playing Russian roulette,” said ...

For years, I’ve watched the barriers my patients face in accessing the treatments I prescribe continue to grow.

For years, I’ve watched the barriers my patients face in accessing the treatments I prescribe continue to grow.

U.S. employers facing surging costs from paying for Novo Nordisk’s Wegovy and similar obesity drugs are hiring virtual healthcare providers like Teladoc to implement weight-loss management programs, a dozen consultants, pharmacy benefit managers, analysts, and providers told Reuters. These programs may require diet and exercise before granting access to the medicines, and in some cases will become employees' sole covered option for medications like Wegovy and Eli Lilly’s riva...

Two Republican lawmakers have filed proposals that would allow Medicaid beneficiaries with “serious mental illness” to avoid a practice known as step therapy in receiving medications.

Operator: Good day, and welcome to the WW International, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions].

Joseph M. Coney, MD, FACS, explores strategies to address treatment obstacles among vulnerable patients and examines the effects of step therapy and prior authorization within a complex health care landscape.

A conversation on barriers which prevent patients from obtaining medications; including cost, co-pays, and prior authorization.

JB Boone, MD, explains PrismRA, a predictive tool designed to determine whether a patient will likely have an inadequate response to a TNF inhibitor.